Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART
Tóm tắt
While the number of HIV-positive patients on antiretroviral therapy (ART) in resource-limited settings has increased dramatically, some patients eligible for treatment do not initiate ART even when it is available to them. Understanding why patients opt out of care, or are unable to opt in, is important to achieving the goal of universal access. We conducted a cross-sectional survey among 400 patients on ART (those who were able to access care) and 400 patients accessing home-based care (HBC), but who had not initiated ART (either they were not able to, or chose not to, access care) in two rural and two urban sites in Zambia to identify barriers to and facilitators of ART uptake. HBC patients were 50% more likely to report that it would be very difficult to get to the ART clinic than those on ART (RR: 1.48; 95% CI: 1.21-1.82). Stigma was common in all areas, with 54% of HBC patients, but only 15% of ART patients, being afraid to go to the clinic (RR: 3.61; 95% CI: 3.12-4.18). Cost barriers differed by location: urban HBC patients were three times more likely to report needing to pay to travel to the clinic than those on ART (RR: 2.84; 95% CI: 2.02-3.98) and 10 times more likely to believe they would need to pay a fee at the clinic (RR: 9.50; 95% CI: 2.24-40.3). In rural areas, HBC subjects were more likely to report needing to pay non-transport costs to attend the clinic than those on ART (RR: 4.52; 95% CI: 1.91-10.7). HBC patients were twice as likely as ART patients to report not having enough food to take ART being a concern (27% vs. 13%, RR: 2.03; 95% CI: 1.71-2.41), regardless of location and gender. Patients in home-based care for HIV/AIDS who never initiated ART perceived greater financial and logistical barriers to seeking HIV care and had more negative perceptions about the benefits of the treatment. Future efforts to expand access to antiretroviral care should consider ways to reduce these barriers in order to encourage more of those medically eligible for antiretrovirals to initiate care.
Tài liệu tham khảo
Souteyrand Y, Akwara P, Warner Smith M, Beusenberg M, Jashi M, Hayashi C, Ekpini R, Baijal P, Gass R, Luo C, Guerma T: Scaling up access to antiretroviral therapy (ART) in low- and middle-income countries: global and regional progress in 2008 [abstract]. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention 2009. Cape Town. WELBD1052009
Central Statistical Office (CSO), Ministry of Health (MOH) Tropical Diseases Research Centre (TDRC), University of Zambia and Macro International Inc: Zambia Demographic and Health Survey 2007. Calverton, Maryland, USA, CSO and Macro International Inc; 2009.
Joint United Nations Programme on HIV/AIDS: Report on the global AIDS epidemic. UNAIDS/08.25E/JC1510E. 2008. Geneva, UNAIDS;
Mapping Progress Towards Universal Access. UNAIDS [http://www.unaids.org/en/knowledgecentre/hivdata/mapping_progress.asp]
Lisulo P, Nicodemus W: Zambia: National long term forecast report for ARV drugs (2008–2015). Lusaka: Zambia, USAID Deliver Project, Task Order 1; 2008.
Krawczyk CS, Funkhouser E, Kilby JM, Vermund SH: Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care 2006,18(Suppl 1):S35-S44.
Gold RS, Hinchy J, Batrouney CG: The reasoning behind decisions not to take up antiretroviral therapy in Australians infected with HIV. Int J STD AIDS 2000, 11:361–370.
Cooper V, Buick D, Horne R, Lambert N, Gellaitry G, Leake H, Fisher M: Perceptions of HAART among gay men who declined a treatment offer: preliminary results from an interview-based study. AIDS Care 2002, 14:319–328.
Gold RS, Ridge DT: "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001, 13:693–708.
Horne R, Cooper V, Gellaitry G, Date HL, Fisher M: Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr 2007, 45:334–341.
Kinsler JJ, Wong MD, Sayles JN, Davis C, Cunningham WE: The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDS 2007, 21:584–592.
Beer L, Fagan JL, Valverde E, Bertolli J, the Never in Care Project: Health-Related Beliefs and Decisions about Accessing HIV Medical Care among HIV-Infected Persons Who Are Not Receiving Care. AIDS Patient Care STDS 2009, 23:785–792.
Posse M, Meheus F, van Asten H, Ven A, Baltussen R: Barriers to access to antiretroviral treatment in developing countries: a review. Tropical Medicine & International Health 2008, 13:904–913.
Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, Urassa M: Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 2006, 20:649–657.
Jones PS: On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia. Health Hum Rights 2005, 8:76–102.
Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M, Aberle-Grasse J, Thambo L, Schouten EJ, Kamoto K, Harries AD: A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS ONE 2007, 2:e620.
Wilson DP, Blower S: How far will we need to go to reach HIV-infected people in rural South Africa? BMC Med 2007, 5:16.
Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, Prozesky HW, Wiysonge CS, Mataya RH: Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 2007, 7:63.
Kwalombota KM, Shumba CD: Influence of gender on access to antiretroviral therapy among African women. XV Int Conf AIDS. 11–16 July 2004; Bangkok, Thailand 2004. Abstract no. TuPeD5158
Plummer ML, Mshana G, Wamoyi J, Shigongo ZS, Hayes RJ, Ross DA, Wight D: 'The man who believed he had AIDS was cured': AIDS and sexually-transmitted infection treatment-seeking behaviour in rural Mwanza, Tanzania. AIDS Care 2006, 18:460–466.
Zambian Ministry of Health: Antiretroviral Therapy for Chronic HIV Infection in Adults and Adolescents. 2007.
Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M: Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006, 296:782–793.
Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, Moatti JP: Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ 2009, 87:279–287.
Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill C, Cooper C: Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006, 3:e438.
Bartlett JA, Hornberger J, Shewade A, Bhor M, Rajagopalan R: Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings. J Int Assoc Physicians AIDS Care 2009, 8:253–68.
Roura M, Wringe A, Busza J, Nhandi B, Mbata D, Zaba B, Urassa M: "Just like fever": a qualitative study on the impact of antiretroviral provision on the normalisation of HIV in rural Tanzania and its implications for prevention. BMC Int Health Hum Rights 2009, 9:22.
Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007, 19:658–665.
Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H: Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr 2006,43(Suppl 1):S123-S126.